Stocktoria
Transcode Therapeutics, Inc. RNAZ
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-04-28
Transcode Therapeutics, Inc. statistics & valuation
Market cap$4.7M
P / B0.5×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -21.3% | -229.7% | -358.7% | -231.5% | -29.8% |
| Return on equity | -335.4% | 830.0% | -1130.3% | -542.0% | -33.5% |
| Current ratio | 6.29 | 2.56 | 1.28 | 1.70 | 8.97 |
Source: SEC EDGAR filings · CIK 0001829635 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.